v3.26.1
Reverse Takeover Transaction with NCAC (Tables)
12 Months Ended
Mar. 31, 2026
Reverse Takeover Transaction with NCAC [Abstract]  
Schedule of Listing Expenses

The calculation of listing expenses is as follows:

 

   Listing Expense 
Consideration paid:    
Shares issued to NCAC shareholders   2,086 
Total consideration shares issued   2,086 
Fair value of the common shares  $17,895.14 
Deemed consideration amount for the common shares issued  $37,336,416 
      
Net identifiable liabilities acquired:     
Cash and cash equivalent  $203 
Accounts payable and accrued liabilities  $(2,136,505)
NCAC promissory note (Note 18)  $(1,413,529)
Derivative warrant liabilities (Note 13)  $(595,358)
Net liabilities acquired  $4,145,189 
      
Listing expense  $41,481,605